Chat with us, powered by LiveChat
BUY TICKETS

SAVE $726 BY FEB. 5

 Speaker Profile

Ph.D., CEO & Co-Founder, ImpriMed

Biography
Sungwon Lim is a seasoned bioengineer and entrepreneur who brings two decades of expertise in academia and biotech. Focused on expediting cancer treatment, his extensive background in therapeutic development led to the creation of ImpriMed. The company provides oncologists with a swift precision diagnostic tool, enabling tailored identification of the most effective available drugs for individual patients. He has received accolades such as the Life Science Voice's Top Industry Leaders Award and the 40 Under 40 in Cancer Award. Dr. Sungwon Lim exemplifies the fusion of biotechnology innovation and compassionate patient care, revolutionizing cancer treatment in the present.


Talk
Connecting the Right Drug to the Right Patient
ImpriMed offers AI-driven decision support to match the right drug to the right patient. The company's live-cell testing platform pinpoints the most effective therapies for individual cancer cases. The technology can also be applied to help pharmaceutical companies identify responder populations for novel drug candidates, de-risking and optimizing the clinical trial process.


AI for Clinical Decision Support Systems Showcase:
ImpriMed

AI-driven functional precision medicine solution for personalizing cancer treatment

 Session Abstract – PMWC 2026 Silicon Valley

Showcase Track S1 - March 5 9.15 A.M.-3.45 P.M.,Showcase Track S1 - March 6 2.30 P.M.-1.15 P.M.


"The PMWC 2026 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative
"

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by FEB. 5TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required